Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nasdaq Biotechnology Ishares ETF (NQ: IBB )

164.83 USD -2.92 (-1.74%)
Official Closing Price Updated: 7:34 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Nasdaq Biotechnology Ishares ETF

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Juno Therapeutics Soars 25% After ROCKET Phase 2 Rocket Trial Resumption
Shares of Juno Therapeutics Inc (NASDAQ: JUNO) soared higher by nearly 25 percent to $34.50 ahead of Wednesday's market open. The ... 
Tags JCAR015 Benzinga News
From Benzinga
When the Bond Sugar High Wears Off
With 3 out of 5 textbook signs that the TLT is done, what does that mean for the market and those filled with the cake they’ve been feasting on post Brexit? 
Tags Bonds
From Blogs - TalkMarkets
Analysts Anticipate IBB To Hit $363
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
T2108 Update – Stocks On the Edge of A Bullish Run
At its high of the day, T2108, the percentage of stocks trading above their 40-day moving averages (DMAs), reached overbought status at 70.7%. 
Tags Currencies/Forex ETF's Stocks / Equities
From Blogs - TalkMarkets
Biotech Rally Up 8% From Brexit Bottom: Rayno Biopharmaceutical Portfolio Update: July 11, 2016
Technicals tell the story as the IBB hit a triple bottom near 240, then rose to 250 at BREXIT event. 
Tags Healthcare
From Blogs - TalkMarkets
Look Ma, 18,000 in the Dow and No Gremlin!
On Friday, with the help of a much better than expected unemployment number along with an increase in wages, up in the air our paraglider went. The Dow soared past 18,000 with nary a gremlin in sight. 
Tags Stocks / Equities Currencies/Forex
From Blogs - TalkMarkets
Seven Up – ETFs Of Interest
Here are seven ETFs of interest and a few thoughts on each, including the gold miners, silver, biotech and agriculture ETFs. 
Tags ETF's Basic Materials / Commodities Pharma/Biotech
From Blogs - TalkMarkets
Good looking setups in the biotech space for next week
Tags SRPT CLVS ACAD
From AC Investor Blog
18,000 in the Dow - A Climb to Nowhere?
External factors have a part in the Dow’s next direction.. Undoubtedly, oil gives the market a deflationary scare. Grain prices fell hard after making substantial gains earlier. 
Tags ETF's Stocks / Equities
From Blogs - TalkMarkets
Best & Riskiest Stocks First Half Recap
Each year, on Jan 1st, Slim gives his predictions for the best and riskiest stocks of the coming year. And at midyear he does a recap. See the astounding results for the first half of 2016. 
Tags Stocks / Equities Technology Pharma/Biotech
From Blogs - TalkMarkets
The Dow Paraglides Towards 18,000
With the Dow closing on Wednesday at 17,918.62, what sort of reverse launch does the rest of the market need to help get the Dow airlifted? 
Tags Stocks / Equities ETF's
From Blogs - TalkMarkets
Investors Flip to Risk-On Approach
 
Tags INDEXDJX:/DJI NYSE:VRX Stock Market Today
From InvestorPlace
Has the Market Baked a Mud Pie or Fudge Cake?
Our Granddad Russell 2000, which ended last week managed to hang onto the 50 daily moving average. If you hope to lick the mixing spoon, it’s this index that gives you the best chance for a sweet... 
Tags ETF's
From Blogs - TalkMarkets
Large Cap Biopharmaceuticals-Valuation Models 2016
The biotech sector has underperformed the market because of the severe correction in August/September of 2015 followed by another downdraft in January 2016 all the result of “bubble” valuations. 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Pockets Filled With Gold
Last week’s market saw its own version of a gold rush. Cash gold ended above the 200 week moving average for the second week in a row. The last time it traded above that moving average was in April... 
Tags Stocks / Equities Gold/Precious Metals ETF's
From Blogs - TalkMarkets
Utilities, Anyone?
The celebratory nature of the stock market is being masked by another telling trend: Defensive sectors are outperforming higher risk areas. 
Tags Stocks / Equities Utilities ETF's
From Blogs - TalkMarkets
Fast Money Traders Share Their Biotech Picks
On CNBC's Fast Money Final Trade, Tim Seymour said that Gilead Sciences, Inc. (NASDAQ: GILD) looks cheap at 7 times price-to-earnings ... 
Tags GILD Media Steve Grasso
From Benzinga
Traders spot relative value in biotech
The iShares NASDAQ Biotechnology ETF was up more than 3 percent on the week, but down nearly 24 percent this year. 
Tags Health Care/Pharmaceuticals Biotechnology and Life Sciences/Biotechnology Investing Pfizer Inc
From CNBC.com News
The Best Seasonal Investments For Q3
Bonds and defensive baskets offer the strongest seasonal tailwinds in Q3.The best industries for Q3 seasonality are biotech, healthcare providers, and software. 
Tags ETF's Bonds
From Blogs - TalkMarkets
Vista Partners Initiates Coverage on Mount TAM Biotechnologies, Inc. (Ticker: MNTM); $3.25 Price Target
From Marketwired News Releases
BRexit Bottom For Biotech Creates Buying Opportunity
Biotech stocks soared yesterday getting relief from the brutal BRexit bashing that scared away all buyers. BRexit has little to do with biopharma but the”risk-off” pall brings caution and a move to... 
Tags Healthcare ETF's Pharma/Biotech
From Blogs - TalkMarkets
Don't Put Away Your Umbrella Just Yet
Yesterday’s potential reversal pattern in its current Bearish phase confirmed today. QQQs ran up to the January 13th high the day it opened higher and then proceeded to tank. It also ran slightly above... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
How Do I Turn Off All The Noise?
As I went through the tweets of those I follow before the market opened today, I literally felt like my head could explode. Opinions, opinions, opinions and more opinions. 
Tags Stocks / Equities Currencies/Forex ETF's
From Blogs - TalkMarkets
Brexit: A Bane for Bumbling Biotech ETFs?
Brexit is the excuse of the moment that many market observers are pointing to explain the near-term struggles of various asset classes and sectors. In some cases, that observation is accurate. In... 
Tags featured biotech IBB
From ETF Trends
Brexit brings an opportunity to reload the portfolio
Assuming that a few of our favorite names take a hit this morning, we should be able to pick up some shares at a nice discount, which is the smart play when investors are panicking. 
Tags General FB IBB
From MarketWatch
The iShares NASDAQ Biotechnology Index (IBB): Biotech Stocks Are Pushing for Recovery
 
Tags NASDAQ:BIIB NASDAQ:AMGN Stocks to Buy
From InvestorPlace
Analysts Anticipate IBB Will Reach $359
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Best Stock Charts - June 23, 2016
We talk about the latest market overview by reviewing different charts. 
Tags Commodities Energy Currencies/Forex
From Blogs - TalkMarkets
The iShares Nasdaq Biotechnology Index (ETF) (IBB): Gravity Calls!
 
Tags NASDAQ:IBB Trading Advice
From InvestorPlace
Sharp Biotech Reversal To Upside Today: IBB Up 2.40%…Update-1
The IBB peaked at $260 and dropped back to settle at $256.56 up only 0.56%. 
Tags Stocks / Equities ETF's Healthcare
From Blogs - TalkMarkets
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.